Escalon Medical Corp (QB) (ESMC)

Thank You.

I'm just in it till it pops and then I'm out of here.

Here's my take. The company has never created a single press release, ever. I cannot invest in a company who has never created a single press release. At least on the otc stock market. If this were a private company that would been fine. Good luck. 

Yes I did - still long.

Hopefully this ends up well!!!!!!

GLTU

Hey you bought this stock too? They just released an 8k about some business they bought. 

2025 and still alive.

No idea what so ever - was hoping you knew, lol...

I still have this. Any idea why it's moving? No news anywhere.

Apparently not...

Anybody still in this gem?

new writeup on ESMC

stock has been dropping and is looking pretty good here

The Good and Bad Sides of $ESMC
http://www.nonamestocks.com/2018/11/the-good-and-bad-sides-of-esmc.html

If I had funds available I might try to buy some at these levels.

On the other hand, there just hasn't been much interest in ESMC for whatever reason...

Down to 15.4c.....
Ooooooouuuuchhhhhhhhhhh.
ps-blood on the street:buy,buy,buy.

volume picking up some. Hoping to get back .30s soon.

Correction.......
From:
"The stated cost of the 4.3 million shares is around 12c"
To:
"the stated cost of the 4.3 million shares is around 15c or $645k/4.3=15c"

My last purchased @30c..............
Down to 18.2c.Ooooouuuuccchhhhhhhhh.
ps-when there is blood on the street:buy,buy,buy.

Yes, that is my understanding. 8-K just out, some leadership changes to the board of directors.

https://ih.advfn.com/p.php?pid=nmona&article=76759617

The shares in the form 4 were part of the financing and Change in Control...

Looks to me like the Form 4 filed on Friday was not a purchase but an award.

Escalon Medical is pretty much under the radar at this point. I think that could change soon.

Agreed. Those .30s being gradually purchased is a good sign...

Maintaining majority voting interest by the management...........
Is telling us someone BIG may be lurking in the background,a player in the retinal device segement??,with intention unknown.

Global Retinal Surgery Device Market 2018-2024 by Segments and Companies - Market to Exceed $3 Billion by 2024 - ResearchAndMarkets.com

https://www.businesswire.com/news/home/20180216005476/en/Global-Retinal-Surgery-Device-Market-2018-2024-Segments

Companies Mentioned

Alcon Laboratories, Inc.
Carl Zeiss
Ellex Medical Lasers
Escalon Medical
Iridex Corporation
Second Sight Medical Products Inc.
Topcon Corporation
Valeant Pharmaceuticals International, Inc.

Disclosure ............................................................
I average up,not down,on this one.Pickup few more shares @30c.
ps-as I expected,MM is offering 65k share blocks at 30c.They are suppressing the price up.wooowwwwww.

value players may discover this during the weekend. This 10Q is deserving of a PR. Dunno if we'll get one though. Good to be in a real company for a change.

L2 showing .28x.30 now. Maybe new highs coming...

One of the main reason I betted on this turd(until yesterday)........
https://www.modmed.com/ophthalmology/
or
this progressive customer give the company credence and a sign of relieve(from risk) for its shareholders.

Thanks! I'm looking forward to seeing how things progress for ESMC.

From 10Q,the share count was 7.6 million........
and after the conversion of note from preferred to common shares,the dilutive share count becomes 11.9(=7.6+4.3). The stated cost of the 4.3 million shares is around 12c,the management is no dummy,and they knew exactly what they were doing,while maintaining majority control:a bit aggressive,up to 67% voting control first,then drop down to 35% when everything said and done.Not too abusive or it could had taken more from the shareholders.

You nailed it.......
"The $500,000 software license revenue(eps=6c) helped a lot, but even without that it(eps=3c)looks good. "
Based on this quarter and going forward,I believe eps=8c is sustainable for 2018,ex-$500K.
In the nutshell:
topline grows at 7%+;
cost stabilized at 54% of revenue;
sg&a is down to 35% of revenue vs 40% in 2017;
R&D is down 4% of revenue.
or
2018 net income=sale*5%,business model is working.

Yes, looks good. Nice share structure too, with 7.5M shares outstanding.

Escalon mentioned here, Ophthalmic Ultrasound System Market Technological Advancement 2018, as one of the leading companies in the market. Nice!

The Leading Companies are Nidek Co. Ltd., Halma plc, Optos plc, Reichert, Inc., Escalon Medical Corp., Ellex Medical Laser Ltd., Quantel Medical, etc.

http://versionevents.com/2018/02/14/ophthalmic-ultrasound-system-market-technological-advancement-2018/

I didn't do the calc -- I just know it is really good for the price. The $500,000 software license revenue helped a lot, but even without that it looks good. And with the debt being moved into pref shares - more good stuff.

I need to look into the $500,000 thing - I wonder if there may be more of those coming down the road. IF so we are in a 10 bagger.

Did I read that right - .09 EPS? There is also the 8-K filing, Change in Control. I agree, should move up from here.

Great 10Q, great stuff here. This is going up a lot more IMO.

New yearly high @25c..........
This baby is on the move.Finally.Woooooowwwwwwww.

From Subsequent Event,10-Q.......
"On February 14, 2018, the Company entered into a Debt Exchange Agreement (the “Exchange Agreement”) with Richard J. DePiano Sr. (“Mr. DePiano”), the Company's Chairman and DP Associates Inc. Profit-Sharing Plan of which Mr. DePiano is the sole owner and sole trustee (the “Holders”). Pursuant to the terms of the Exchange Agreement, effective February 15, 2018, the Holders are exchanging a total of $645,000 principal amount of debt the Company owes the Holders (See Note 6) for 2,000,000 shares of Series A Convertible Preferred Stock (the “Preferred Stock”).

Each share the Preferred Stock entitles the Holder thereof to 13 votes per share and will vote together with all other classes and series of stock of the Company as a single class on all actions to be taken by the Company’s stockholders. As a result of this voting power, the Holders as of February 15, 2018 beneficially own approximately 77.49% of the voting power on all actions to be taken by the Company’s shareholders."

They(management) have definitely been preparing for a takeover,hostile or friendly. wooowwwwww.

Numbers are out.....
eps=9c.WWWooowwwwwww.
ps-net income is 43% of its MC or pe<1.This stock is WAY WAY UNDER VALUED.wooowwwwww.

Volume @16c bid....
is only 100k shares,someone wants bad.Woowwww.

Volume is creeping up slowly.......
bid 17c,ask 18c last trade price @22c.Woooowwww.

I am in.......
With MC=$1.3 million or 17c per share,I believe this company is way too cheap;and more than likely it would continue its 10%+ q/q topline growth since last q.This may seen too short of a period to be sure but at this MC,again,it is a GREAT bargain.

Read the article in your post......
I believe this company may be back from ashes and starting outperform as the article noted.I could be wrong,but the risk/reward is just too attracting to ignore.

Hello..........
Anyone here?Is this dog coming back??Next q should tell.

Any water here Rango?

What is with jump in volume? Somebody finally find this company?

T

This one just keeps on giving, slow and steady!

new recommendation on esmc from noted financial pub since 1984
http://saadvisory.com/update/archive/January-02-2017.htm

Pay attention

ESMC delisted from the Nasdaq to the OTC:

http://otce.finra.org/DLAdditions

Earnings looks nice! Any update on ultrasound new platform?

I am with a small position @1.65

ESMC - 151% Kabooooom! Busy day ... flipper's dream. :)




MORE IN THE TANK HERE? $1.41?